Skip to content

Exercise Training Adherence After Cardiac Rehabilitation in Coronary Heart Disease Patients

Supported Home-based Exercise Training Versus Usual Care After Cardiac Rehabilitation. A Randomized Controlled Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01246570
Enrollment
48
Registered
2010-11-23
Start date
2010-11-30
Completion date
2014-01-31
Last updated
2014-09-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Coronary Disease

Keywords

exercise, heart, coronary disease, rehabilitation

Brief summary

It is known that organized cardiac rehabilitation is effective in improving exercise capacity in coronary heart disease patients. Less is known about the long-term results after cardiac rehabilitation. Earlier studies have shown that many patients quit exercising when no longer attending formal rehabilitation. The investigators wish to investigate the effect of a maintenance program after ending a rehabilitation program, and to compare this to usual care. The investigators hypothesis is that the maintenance program will result in higher exercise capacity and more physical activity compared to usual care.

Interventions

BEHAVIORALExercise training

The patients will meet for organized exercise training once monthly and also exercise testing every third month.

OTHERControl

The patients will receive the usual care provided by the hospitals and the community health services

Sponsors

Norwegian University of Science and Technology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
35 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* coronary heart disease patients

Exclusion criteria

* unstable angina pectoris * hemodynamic significant valve disease (\> New York Heart Association class II) * pregnancy * left ventricular ejection fraction \<30% * kidney failure (creatinin \> 140) * uncontrolled hypertension

Design outcomes

Primary

MeasureTime frameDescription
Peak oxygen uptakebaseline and 12 monthsThe change in peak oxygen uptake from baseline to 12 months after baseline. In the intervention group, the peak oxygen uptake will be measured also every 3 months during the intervention period, and this will be reported

Secondary

MeasureTime frameDescription
Hospital readmissionbaseline and 12 monthsIt will be recorded whether the patients is readmitted to hospital during the intervention period
Deathbaseline and 12 months
Endothelial functionbaseline and 12 monthsFlow mediated dilatation of the brachial artery, measured by ultrasound. Changes in flow-mediated dilatation from baseline to 12 months after baseline will be recorded
Myocardial infarctionbaseline and 12 monthsDiagnosis of myocardial infarction during the intervention period will be recorded
Blood markersbaseline and 12 monthsLipoproteins, c-peptide, ferritin, glucose, high sensitive c-reactive protein will be analysed. Also, blood will be stored for later analyses not yet planned. Changes in markers from baseline to 12 months after baseline will be recorded
Physical activitybaseline and 12 monthsQuestionnaire and physical activity sensor (armband) will be measured at baseline and after 12 months.
Quality of lifebaseline and 12 monthsMac New health related quality of life questionnaire. Changes in quality of life from baseline to 12 months after baseline will be recorded

Countries

Norway

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026